BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32023909)

  • 1. Herb-Drug Interaction of Red Ginseng Extract and Ginsenoside Rc with Valsartan in Rats.
    Jeon JH; Lee S; Lee W; Jin S; Kwon M; Shin CH; Choi MK; Song IS
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside-perpetrated herb-drug interactions on OATP1B3.
    Jiang R; Dong J; Li X; Du F; Jia W; Xu F; Wang F; Yang J; Niu W; Li C
    Br J Pharmacol; 2015 Feb; 172(4):1059-73. PubMed ID: 25297453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple circulating saponins from intravenous ShenMai inhibit OATP1Bs in vitro: potential joint precipitants of drug interactions.
    Olaleye OE; Niu W; Du FF; Wang FQ; Xu F; Pintusophon S; Lu JL; Yang JL; Li C
    Acta Pharmacol Sin; 2019 Jun; 40(6):833-849. PubMed ID: 30327544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ginsenosides following repeated oral administration of red ginseng extract significantly differ between species of experimental animals.
    Jeon JH; Lee J; Choi MK; Song IS
    Arch Pharm Res; 2020 Dec; 43(12):1335-1346. PubMed ID: 33225388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of 13 Ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, Compound K, 20(
    Jin S; Jeon JH; Lee S; Kang WY; Seong SJ; Yoon YR; Choi MK; Song IS
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31323835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Red Ginseng Extract on the Pharmacokinetics and Elimination of Methotrexate via Mrp2 Regulation.
    Lee S; Kwon M; Choi MK; Song IS
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30424502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantification of twenty-one ginsenosides and their three aglycones in rat plasma by a developed UFLC-MS/MS assay: Application to a pharmacokinetic study of red ginseng.
    Zhou QL; Zhu DN; Yang YF; Xu W; Yang XW
    J Pharm Biomed Anal; 2017 Apr; 137():1-12. PubMed ID: 28086165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
    Takahashi T; Uno Y; Yamazaki H; Kume T
    Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OATP1B3 Expression and Function is Modulated by Coexpression with OCT1, OATP1B1, and NTCP.
    Zhang Y; Ruggiero M; Hagenbuch B
    Drug Metab Dispos; 2020 Aug; 48(8):622-630. PubMed ID: 32482756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant Administration of Red Ginseng Extract with Lactic Acid Bacteria Increases the Plasma Concentration of Deglycosylated Ginsenosides in Healthy Human Subjects.
    Jeon JH; Park JH; Jeon SY; Pang M; Choi MK; Song IS
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
    Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
    J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions.
    Pintusophon S; Niu W; Duan XN; Olaleye OE; Huang YH; Wang FQ; Li YF; Yang JL; Li C
    Acta Pharmacol Sin; 2019 Oct; 40(10):1351-1363. PubMed ID: 31358899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of ginsenosides in human glucocorticoid receptor binding, transactivation, and transrepression.
    Hu C; Lau AJ; Wang R; Chang TKH
    Eur J Pharmacol; 2017 Nov; 815():501-511. PubMed ID: 29031898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic compatibility of ginsenosides and Schisandra Lignans in Shengmai-san: from the perspective of p-glycoprotein.
    Liang Y; Zhou Y; Zhang J; Rao T; Zhou L; Xing R; Wang Q; Fu H; Hao K; Xie L; Wang G
    PLoS One; 2014; 9(6):e98717. PubMed ID: 24922060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease.
    Li Z; Tian S; Wu Z; Xu X; Lei L; Li Y; Wang B; Huang Y
    J Ethnopharmacol; 2021 Nov; 280():114469. PubMed ID: 34329714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport properties of valsartan, sacubitril and its active metabolite (LBQ657) as determinants of disposition.
    Hanna I; Alexander N; Crouthamel MH; Davis J; Natrillo A; Tran P; Vapurcuyan A; Zhu B
    Xenobiotica; 2018 Mar; 48(3):300-313. PubMed ID: 28281384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of schisandra lignans on the absorption of protopanaxadiol-type ginsenosides mediated by P-glycoprotein and protopanaxatriol-type ginsenosides mediated by CYP3A4.
    Li Y; Yang K; Zhao L; Xu C; Zhou W; Wang Z; Hu H; You Y
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117057. PubMed ID: 37597677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenosides, ingredients of the root of Panax ginseng, are not substrates but inhibitors of sodium-glucose transporter 1.
    Gao S; Kushida H; Makino T
    J Nat Med; 2017 Jan; 71(1):131-138. PubMed ID: 27619505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Lactic Acid Bacteria on the Pharmacokinetics and Metabolism of Ginsenosides in Mice.
    Jeon JH; Lee J; Park JH; Lee CH; Choi MK; Song IS
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.
    Farasyn T; Crowe A; Hatley O; Neuhoff S; Alam K; Kanyo J; Lam TT; Ding K; Yue W
    J Pharm Sci; 2019 Oct; 108(10):3443-3456. PubMed ID: 31047942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.